Live feed20:06:23·471dINSIDERFilingvia QuantisnowEVP & Chief Commercial Officer Harris Erik was granted 35,256 shares and sold $635,836 worth of shares (15,103 units at $42.10), increasing direct ownership by 31% to 87,855 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RARE· Ultragenyx Pharmaceutical Inc.Health CareOriginal source
